Chi-Mu Chuang Selected Research

Chi-Mu Chuang Research Topics

Disease

20	Neoplasms (Cancer) 11/2021 - 05/2008
10	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 04/2009
5	Ovarian Epithelial Carcinoma 01/2019 - 01/2015
4	Residual Neoplasm 05/2016 - 09/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021 - 05/2008
2	Infections 01/2019 - 11/2013
2	Inflammation (Inflammations) 11/2017 - 03/2015
2	Endometrial Neoplasms (Endometrial Cancer) 01/2016 - 03/2015
1	Bacterial Vaginosis 01/2022
1	Carcinogenesis 11/2021
1	Vaginal Discharge 01/2019
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 06/2018
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 06/2018
1	Clear Cell Adenocarcinoma 06/2018
1	Neurofibroma 02/2018
1	Carcinoma (Carcinomatosis) 04/2015
1	Aneuploidy (Aneuploid) 04/2015
1	Endometriosis 03/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Hypersensitivity (Allergy) 01/2015
1	Vaccinia 07/2009

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2008
4	Therapeutic UsesIBA 12/2021 - 05/2008
4	PlatinumIBA 11/2021 - 09/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 05/2016 - 04/2014
4	AntigensIBA 04/2010 - 05/2008
4	DNA VaccinesIBA 04/2010 - 05/2008
3	Peptides (Polypeptides)IBA 01/2022 - 04/2009
3	Pharmaceutical PreparationsIBA 05/2019 - 04/2014
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 05/2008
2	Liposomes (Liposome)IBA 05/2019 - 01/2015
2	CalreticulinIBA 04/2010 - 05/2008
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2009 - 01/2009
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 05/2009 - 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Bevacizumab (Avastin)FDA Link 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 11/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	olaparibIBA 10/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020
1	EnzymesIBA 10/2020
1	GlutaminaseIBA 10/2020
1	Glutamine (L-Glutamine)FDA Link 10/2020
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020
1	CB-839IBA 10/2020
1	NucleotidesIBA 10/2020
1	AntioxidantsIBA 10/2020
1	Antimicrobial PeptidesIBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Acridine OrangeIBA 01/2019
1	GlypicansIBA 06/2018
1	Tumor Biomarkers (Tumor Markers)IBA 06/2018
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2018
1	NFI Transcription FactorsIBA 06/2018
1	Keratin-7 (Cytokeratin 7)IBA 06/2018
1	mesoglycanIBA 02/2018
1	Hormones (Hormone)IBA 11/2017
1	Oxidoreductases (Dehydrogenase)IBA 11/2017
1	PeriostinIBA 01/2016
1	liposomal doxorubicin (Doxil)FDA Link 04/2015
1	dichlorobis(azomycin)platinum IIIBA 04/2015
1	Estrogens (Estrogen)FDA Link 03/2015
1	IntegrinsIBA 01/2015
1	GlucocorticoidsIBA 01/2015
1	Excipients (Suspending Agents)IBA 04/2014
1	Ether (Diethyl Ether)IBA 04/2014
1	AnhydridesIBA 04/2014
1	MicroRNAs (MicroRNA)IBA 12/2013
1	Imiquimod (Aldara)FDA LinkGeneric 04/2010
1	Immunomodulating AgentsIBA 04/2010
1	OvalbuminIBA 07/2009
1	ApigeninIBA 05/2009
1	OligodeoxyribonucleotidesIBA 04/2009
1	CPG-oligonucleotideIBA 04/2009
1	CathelicidinsIBA 04/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2009
1	LigandsIBA 04/2009
1	Monoclonal AntibodiesIBA 01/2009
1	VaccinesIBA 01/2009
1	A-Form DNA (A-DNA)IBA 01/2009

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 07/2022 - 05/2008
7	Therapeutics 10/2020 - 05/2009
5	Immunotherapy 04/2010 - 05/2008
4	Cytoreduction Surgical Procedures 05/2016 - 01/2012
3	Investigational Therapies (Experimental Therapy) 04/2010 - 04/2009
1	Catheters 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 09/2014
1	Microspheres (Microsphere) 04/2014